Imaging Updates in Rheumatoid Arthritis

Abstract

Rheumatoid arthritis is a common chronic inflammatory arthritis, primarily characterized by proliferative synovitis of the small joints of the appendicular skeleton. Rapidly evolving treatment regimens for rheumatoid arthritis patients, including conventional and biologic disease-modifying antirheumatic drugs, promise improved quality of life and prognosis. These treatments necessitate earlier clinical detection of rheumatoid arthritis, a goal that has forever changed the role of imaging in this pursuit. This review discusses the dominant imaging modalities in state-of-the-art rheumatoid arthritis management: radiography, magnetic resonance imaging, and ultrasound. It focuses on hand and wrist evaluation, with key relevant findings detected by each modality and recent evidence supporting them. Emerging techniques are also described in this discussion to understand likely future radiologic contributions to rheumatoid arthritis diagnosis and management.

Keywords

rheumatoid arthritis - inflammatory arthritis - erosions - synovitis

Publikationsverlauf

Artikel online veröffentlicht:
31. März 2025

• References

• 1 Venetsanopoulou AI, Alamanos Y, Voulgari PV, Drosos AA. Epidemiology and risk factors for rheumatoid arthritis development. Mediterr J Rheumatol 2023; 34 (04) 404-413
• 2 Allaire S, Wolfe F, Niu J, Lavalley MP. Contemporary prevalence and incidence of work disability associated with rheumatoid arthritis in the US. Arthritis Rheum 2008; 59 (04) 474-480
• 3 Cabling MG, Sandhu VK, Downey CD, Torralba KD. Cardiovascular disease and bone health in aging female rheumatic disease populations: a review. Womens Health (Lond Engl) 2023; 19: 17 455057231155286
• 4 Koene RJ, Prizment AE, Blaes A, Konety SH. Shared risk factors in cardiovascular disease and cancer. Circulation 2016; 133 (11) 1104-1114
• 5 Birnbaum H, Pike C, Kaufman R, Marynchenko M, Kidolezi Y, Cifaldi M. Societal cost of rheumatoid arthritis patients in the US. Curr Med Res Opin 2010; 26 (01) 77-90
• 6 Hassan R, Faruqui H, Alquraa R, Eissa A, Alshaiki F, Cheikh M. Classification criteria and clinical practice guidelines for rheumatic diseases. In: Skills in Rheumatology. Singapore: Springer; 2021: 521-566
• 7 Sizova L. Diagnostic accuracy of the 2002 EULAR Criteria for the Clinical Suspicion of Rheumatoid Arthritis and the sensitivity of the new 2010 ACR/EULAR Classification Criteria in “Early Arthritis.”. Turkish Journal of Rheumatology 2011; 26 (01) 7-12
• 8 Britsemmer K, Ursum J, Gerritsen M, van Tuyl LH, van Schaardenburg D. Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria. Ann Rheum Dis 2011; 70 (08) 1468-1470
• 9 Aletaha D, Neogi T, Silman AJ. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62 (09) 2569-2581
• 10 Nishimura K, Sugiyama D, Kogata Y. et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007; 146 (11) 797-808
• 11 De Rycke L, Peene I, Hoffman IEA. et al. Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations. Ann Rheum Dis 2004; 63 (12) 1587-1593
• 12 Dibrov DA, Avdeeva AS, Diatroptov ME, Nasonov EL. Anti-carbamylated protein antibodies in ACPA-negative and ACPA-positive patients with rheumatoid arthritis. Dokl Biochem Biophys 2024; 517 (01) 235-242
• 13 Balaji D, Mohanasundaram K, Gopalakrishnan KV, Suthakaran PK. Anti-carbamylated protein antibodies positivity in rheumatoid arthritis and its association with rheumatoid factor and anti-cyclic citrullinated protein antibodies. Cureus 2024; 16 (07) e63652
• 14 Paalanen K, Puolakka K, Nikiphorou E, Hannonen P, Sokka T. Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study. Rheumatology (Oxford) 2021; 60 (05) 2391-2395 . Published correction appears in Rheumatology (Oxford) 2021;14;60(5):2493–2494
• 15 Bugatti S, Manzo A, Montecucco C, Caporali R. The clinical value of autoantibodies in rheumatoid arthritis. Front Med (Lausanne) 2018; 5: 339-339
• 16 Ostendorf B, Scherer A, Mödder U, Schneider M. Diagnostic value of magnetic resonance imaging of the forefeet in early rheumatoid arthritis when findings on imaging of the metacarpophalangeal joints of the hands remain normal. Arthritis Rheum 2004; 50 (07) 2094-2102
• 17 Devlin J, Lilley J, Gough A. et al. Clinical associations of dual-energy X-ray absorptiometry measurement of hand bone mass in rheumatoid arthritis. Br J Rheumatol 1996; 35 (12) 1256-1262
• 18 Harrison BJ, Hutchinson CE, Adams J, Bruce IN, Herrick AL. Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis 2002; 61 (11) 1007-1011
• 19 Szentpetery A, McKenna MJ, Murray BF. et al. Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis. J Rheumatol 2013; 40 (05) 653-662
• 20 Alenfeld FE, Diessel E, Brezger M, Sieper J, Felsenberg D, Braun J. Detailed analyses of periarticular osteoporosis in rheumatoid arthritis. Osteoporos Int 2000; 11 (05) 400-407
• 21 Ezzati F, Pezeshk P. Radiographic findings of inflammatory arthritis and mimics in the hands. Diagnostics (Basel) 2022; 12 (09) 2134
• 22 Matthijssen XME, Akdemir G, Markusse IM. et al. Age affects joint space narrowing in patients with early active rheumatoid arthritis. RMD Open 2016; 2 (02) e000338
• 23 Aoki T, Fujii M, Yamashita Y. et al. Tomosynthesis of the wrist and hand in patients with rheumatoid arthritis: comparison with radiography and MRI. AJR Am J Roentgenol 2014; 202 (02) 386-390
• 24 Døhn UM, Ejbjerg BJ, Hasselquist M. et al. Detection of bone erosions in rheumatoid arthritis wrist joints with magnetic resonance imaging, computed tomography and radiography. Arthritis Res Ther 2008; 10 (01) R25
• 25 Dixey J, Solymossy C, Young A. Early RA Study. Is it possible to predict radiological damage in early rheumatoid arthritis (RA)? A report on the occurrence, progression, and prognostic factors of radiological erosions over the first 3 years in 866 patients from the Early RA Study (ERAS). J Rheumatol Suppl 2004; 69: 48-54
• 26 Schett G, Gravallese E. Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment. Nat Rev Rheumatol 2012; 8 (11) 656-664
• 27 Freeston JE, Bird P, Conaghan PG. The role of MRI in rheumatoid arthritis: research and clinical issues. Curr Opin Rheumatol 2009; 21 (02) 95-101
• 28 Sudoł-Szopińska I, Jans L, Teh J. Rheumatoid arthritis: what do MRI and ultrasound show. J Ultrason 2017; 17 (68) 5-16
• 29 Navalho M, Resende C, Rodrigues AM. et al. Bilateral MR imaging of the hand and wrist in early and very early inflammatory arthritis: tenosynovitis is associated with progression to rheumatoid arthritis. Radiology 2012; 264 (03) 823-833
• 30 Salaffi F, Carotti M, Di Carlo M. et al. Magnetic resonance imaging (MRI)-based semi-quantitative methods for rheumatoid arthritis: from scoring to measurement. J Clin Med 2024; 13 (14) 4137
• 31 Woodworth TG, Morgacheva O, Pimienta OL, Troum OM, Ranganath VK, Furst DE. Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review. Rheumatology (Oxford) 2017; 56 (07) 1177-1188
• 32 Kirchgesner T, Stoenoiu M, Durez P, Michoux N, Vande Berg B. MRI of hands with early rheumatoid arthritis: usefulness of three-point Dixon sequences to quantitatively assess disease activity. J Belg Soc Radiol 2022; 106 (01) 1
• 33 Ostergaard M, Conaghan PG, O'Connor P. et al. Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection—does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?. J Rheumatol 2009; 36 (08) 1806-1810
• 34 Stomp W, Krabben A, van der Heijde D. et al. Aiming for a shorter rheumatoid arthritis MRI protocol: can contrast-enhanced MRI replace T2 for the detection of bone marrow oedema?. Eur Radiol 2014; 24 (10) 2614-2622
• 35 Hodgson R, Grainger A, O'Connor P, Barnes T, Connolly S, Moots R. Dynamic contrast enhanced MRI of bone marrow oedema in rheumatoid arthritis. Ann Rheum Dis 2008; 67 (02) 270-272
• 36 Ramalho J, Semelka RC, Ramalho M, Nunes RH, AlObaidy M, Castillo M. Gadolinium-based contrast agent accumulation and toxicity: an update. AJNR Am J Neuroradiol 2016; 37 (07) 1192-1198
• 37 Iyad N, S Ahmad M, Alkhatib SG, Hjouj M. Gadolinium contrast agents—challenges and opportunities of a multidisciplinary approach: literature review. Eur J Radiol Open 2023; 11: 100503
• 38 Frenken M, Rübsam G, Mewes A. et al. To contrast or not to contrast? On the role of contrast enhancement in hand MRI studies of patients with rheumatoid arthritis. Diagnostics (Basel) 2022; 12 (02) 465
• 39 Aydıngöz Ü, Yıldız AE, Ergen FB. Zero echo time musculoskeletal MRI: technique, optimization, applications, and pitfalls. Radiographics 2022; 42 (05) 1398-1414
• 40 Massa HA, Johnson JM, McMillan AB. Comparison of deep learning synthesis of synthetic CTs using clinical MRI inputs. Phys Med Biol 2020; 65 (23) 23NT03
• 41 Florkow MC, Zijlstra F, Willemsen K. et al. Deep learning-based MR-to-CT synthesis: the influence of varying gradient echo-based MR images as input channels. Magn Reson Med 2020; 83 (04) 1429-1441
• 42 Ulas ST, Ziegeler K, Richter ST. et al. CT-like images in MRI improve specificity of erosion detection in patients with hand arthritis: a diagnostic accuracy study with CT as standard of reference. RMD Open 2022; 8 (01) e002089
• 43 Boeters DM, Nieuwenhuis WP, van Steenbergen HW, Reijnierse M, Landewé RBM, van der Helm-van Mil AHM. Are MRI-detected erosions specific for RA? A large explorative cross-sectional study. Ann Rheum Dis 2018; 77 (06) 861-868
• 44 McQueen FM. Bone marrow edema and osteitis in rheumatoid arthritis: the imaging perspective. Arthritis Res Ther 2012; 14 (05) 224
• 45 Dalbeth N, Smith T, Gray S. et al. Cellular characterisation of magnetic resonance imaging bone oedema in rheumatoid arthritis; implications for pathogenesis of erosive disease. Ann Rheum Dis 2009; 68 (02) 279-282
• 46 Ejbjerg B, Narvestad E, Rostrup E. et al. Magnetic resonance imaging of wrist and finger joints in healthy subjects occasionally shows changes resembling erosions and synovitis as seen in rheumatoid arthritis. Arthritis Rheum 2004; 50 (04) 1097-1106
• 47 Tamai M, Kawakami A, Uetani M. et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum 2009; 61 (06) 772-778
• 48 Tamai M, Kawakami A, Uetani M. et al. The presence of anti-cyclic citrullinated peptide antibody is associated with magnetic resonance imaging detection of bone marrow oedema in early stage rheumatoid arthritis. Ann Rheum Dis 2006; 65 (01) 133-134
• 49 McQueen FM, Ostendorf B. What is MRI bone oedema in rheumatoid arthritis and why does it matter?. Arthritis Res Ther 2006; 8 (06) 222
• 50 Hetland ML, Ejbjerg B, Hørslev-Petersen K. et al; CIMESTRA study group. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis 2009; 68 (03) 384-390
• 51 Burke CJ, Alizai H, Beltran LS, Regatte RR. MRI of synovitis and joint fluid. J Magn Reson Imaging 2019; 49 (06) 1512-1527
• 52 Schwenzer NF, Kötter I, Henes JC. et al. The role of dynamic contrast-enhanced MRI in the differential diagnosis of psoriatic and rheumatoid arthritis. AJR Am J Roentgenol 2010; 194 (03) 715-720
• 53 Zhang B, Xiao L, Zhou H, Li M, Wang J, Guo L. Application of dynamic contrast-enhanced MRI in the diagnosis of rheumatoid arthritis. Contrast Media Mol Imaging 2022; 2022: 3055465-3055465
• 54 McQueen FM. The MRI view of synovitis and tenosynovitis in inflammatory arthritis: implications for diagnosis and management. Ann N Y Acad Sci 2009; 1154 (01) 21-34
• 55 Biehl C, Rupp M, Kern S, Heiss C, ElKhassawna T, Szalay G. Extensor tendon ruptures in rheumatoid wrists. Eur J Orthop Surg Traumatol 2020; 30 (08) 1499-1504
• 56 Botar-Jid C, Bolboaca S, Fodor D. et al. Gray scale and power Doppler ultrasonography in evaluation of early rheumatoid arthritis. Med Ultrason 2010; 12 (04) 300-305
• 57 Xu H, Zhang Y, Zhang H, Wang C, Mao P. Comparison of the clinical effectiveness of US grading scoring system vs MRI in the diagnosis of early rheumatoid arthritis (RA). J Orthop Surg Res 2017; 12 (01) 152
• 58 Borg F, Agrawal S, Dasgupta B. The use of musculoskeletal ultrasound in patient education. Ann Rheum Dis 2008; 67: 419
• 59 Patil P, Dasgupta B. Role of diagnostic ultrasound in the assessment of musculoskeletal diseases. Ther Adv Musculoskelet Dis 2012; 4 (05) 341-355
• 60 Naredo E, Bonilla G, Gamero F, Uson J, Carmona L, Laffon A. Assessment of inflammatory activity in rheumatoid arthritis: a comparative study of clinical evaluation with grey scale and power Doppler ultrasonography. Ann Rheum Dis 2005; 64 (03) 375-381
• 61 Terslev L, Naredo E, Aegerter P. et al. Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce - Part 2: reliability and application to multiple joints of a standardised consensus-based scoring system. RMD Open 2017; 3 (01) e000427
• 62 Wakefield RJ, Balint PV, Szkudlarek M. et al; OMERACT 7 Special Interest Group. Musculoskeletal ultrasound including definitions for ultrasonographic pathology. J Rheumatol 2005; 32 (12) 2485-2487
• 63 Lai KL, Chen DY, Wen MC. et al. What does power Doppler signal indicate in rheumatoid synovitis? A point of view from synovial histopathology. J Chin Med Assoc 2018; 81 (04) 383-386
• 64 Diao XH, Shen Y, Chen L. et al. Superb microvascular imaging is as sensitive as contrast-enhanced ultrasound for detecting synovial vascularity in rheumatoid arthritis. Quant Imaging Med Surg 2022; 12 (05) 2866-2876
• 65 Platzgummer H, Schueller G, Grisar J, Weber M, Schueller-Weidekamm C. Quantification of synovitis in rheumatoid arthritis: do we really need quantitative measurement of contrast-enhanced ultrasound?. Eur J Radiol 2009; 71 (02) 237-241
• 66 Yu X, Li Z, Ren M, Xi J, Wu J, Ji Y. Superb microvascular imaging (SMI) for evaluating hand joint lesions in patients with rheumatoid arthritis in clinical remission. Rheumatol Int 2018; 38 (10) 1885-1890
• 67 Baillet A, Gaujoux-Viala C, Mouterde G. et al. Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) 2011; 50 (06) 1137-1147
• 68 Zayat AS, Ellegaard K, Conaghan PG. et al. The specificity of ultrasound-detected bone erosions for rheumatoid arthritis. Ann Rheum Dis 2015; 74 (05) 897-903